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Abstract
Background: Investigations on pulmonary macrophages (MF) mostly focus on alveolar MF (AM) as a well-defined
cell population. Characteristics of MF in the interstitium, referred to as lung interstitial MF (IM), are rather
ill-defined. In this study we therefore aimed to elucidate differences between AM and IM obtained from human
lung tissue.
Methods: Human AM and IM were isolated from human non-tumor lung tissue from patients undergoing lung
resection. Cell morphology was visualized using either light, electron or confocal microscopy. Phagocytic activity
was analyzed by flow cytometry as well as confocal microscopy. Surface marker expression was measured by flow
cytometry. Toll-like receptor (TLR) expression patterns as well as cytokine expression upon TLR4 or TLR9 stimulation
were assessed by real time RT-PCR and cytokine protein production was measured using a fluorescent bead-based
immunoassay.
Results: IM were found to be smaller and morphologically more heterogeneous than AM, whereas phagocytic
activity was similar in both cell types. HLA-DR expression was markedly higher in IM compared to AM. Although
analysis of TLR expression profiles revealed no differences between the two cell populations, AM and IM clearly
varied in cell reaction upon activation. Both MF populations were markedly activated by LPS as well as DNA
isolated from attenuated mycobacterial strains (M. bovis H37Ra and BCG). Whereas AM expressed higher amounts
of inflammatory cytokines upon activation, IM were more efficient in producing immunoregulatory cytokines, such
as IL10, IL1ra, and IL6.
Conclusion: AM appear to be more effective as a non-specific first line of defence against inhaled pathogens,
whereas IM show a more pronounced regulatory function. These dissimilarities should be taken into consideration
in future studies on the role of human lung MF in the inflammatory response.
Introduction
Macrophages (MF) are cells of the body’s defence sys-
tem widely distributed in the peripheral and lymphoid
tissues. They differentiate from monocytes, which repre-
sent leukocytes circulating in the blood. MF are phago-
cytic cells and act both in the innate as well as in the
acquired immune system. MF express MHC-II mole-
cules and therefore function as antigen-presenting cells.
In addition, MF secrete numerous cytokines making
them key factors in the modulation of immune func-
tions. The production of pro-inflammatory cytokines by
macrophages, such as TNF-a, induces a typical Th1, i.e.
ap r o - i n f l a m m a t o r yi m m u n er e s p o n s e .O nt h eo t h e r
hand, macrophages can also induce a Th2 response by
secreting anti-inflammatory mediators, such as IL10 [1].
Alveolar macrophages (AM) located in lung alveoli
play a central role in pulmonary innate immunity as the
first line of defence against inhaled particles and patho-
gens. Besides their function in the defence against infec-
tious diseases they are known to play a role in
inflammatory airway diseases, such as chronic
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late immune responses in allergic disease [3].
In contrast to alveolar macrophages as a rather well-
defined macrophage population, which are commonly
obtained by bronchoalveolar lavage (BAL), little is
known about another potential macrophage-like cell
population in human lungs referred to as lung intersti-
tial macrophages (IM).
Studies using primary rat or mouse macrophages sug-
gest that AM are more effective than IM in producing
c y t o k i n e si n v o l v e di na na n t i m i c r o b i a ld e f e n c ew h e r e a s
IM express higher levels of MHC-II molecules and have
a more pronounced accessory function [4,5]. The rele-
vance of these observations is not described in the lit-
erature. One of the very few studies investigating
functional differences between human AM and IM
describes a phagocytic activity of AM compared to IM
[6]. Moreover, a higher production of matrix metallo-
proteinases in IM compared to AM [7] has been
reported, indicating that IM might play a more pro-
nounced role in tissue remodelling.
Lung dendritic cells have recently gained marked
scientific interest. This cell type resides in small num-
bers in the lung interstitial tissue in close proximity to
both the large airways and the alveoli and is specialized
for antigen presentation and accessory function [4,8,9].
A study using mouse models only recently revealed that
IM are able to inhibit maturation and migration of lung
dendritic cells [5]. This makes IM the cell type responsi-
ble for the suppression of allergic reactions towards
harmless antigens. The relevance of these findings for
humans, however, need to be confirmed.
Over the last several years, Toll-like receptors (TLRs)
have emerged as important transducers of the innate
immune response. TLRs act as a first line of host immu-
nity against various pathogens. Presently, ten human TLRs
are known, which recognize pathogen-associated molecu-
lar patterns including bacterial cell wall components such
as lipoproteins (TLR1/2 or TLR1/6 dimers) or lipopolysac-
charide (LPS, TLR4), bacterial flagellin (TLR5), viral RNA
(TLR3, 7 and 8) as well as bacterial DNA (TLR9) [10].
In order to investigate the role of AM and IM in the
pathogenesis of human lung disease, aim of the present
study was to characterize respective cell populations iso-
lated from human lung tissue. Since Toll-like receptors
represent key mediators of infectious [11] as well as
non-infectious lung disease [12] a special focus was laid
on potential differences in AM and IM with respect to
activation via TLR4 and TLR9.
Methods
Materials
FITC-labelled anti-CD14 (61/D3) and FITC-IgG1 were
obtained from eBioscience (San Diego, CA, USA),
PE-labelled anti-HLA-DR (AB3), PE-labelled anti-CD68
(KP1), FITC-labelled anti-CD1a (NA1/34) as well as
PE-IgG2a , FITC-IgG2a  and PE-IgG1  isotype con-
trols were purchased from Dako (Carpinteria, CA,
USA). PE-labelled anti-CD83 (HB15e), PE-labelled CD90
(5E10), and PE-IgG1  were from BD Biosciences (San
Jose, CA, USA). Other chemicals were obtained from
Sigma-Aldrich (St. Louis, MO, USA) or Roth (Karlsruhe,
Germany) if not marked otherwise.
Bacterial culture
Mycobacteria (M. bovis BCG, wild-type M. bovis, H37Rv,
H37Ra) were grown in Middlebrook 7H9 broth contain-
ing 10% ADC, 0.2% glycerol and 0.05% Tween 80 (7H9-
ADCT) or on Middlebrook 7H10 agar containing OADC
(Becton Dickinson, Franklin Lake, NJ, USA), 0.5% gly-
cerol and antifungal cycloheximide (100 μg/ml) (Sigma-
Aldrich, St. Louis, MO, USA). Antibiotics included
hygromycin (50 μg/ml) and kanamycin (25 μg/ml).
Cell culture
Alveolar macrophages
Alveolar macrophages were isolated from human non-
tumor lung tissue, which was obtained from patients
undergoing lung resection. The use of human material
for isolation of primary cells was reviewed and approved
by the local Ethics Committees (State Medical Board of
Registration, Saarland, Germany). Isolation was per-
formed referring to a protocol for the recovery of type
II pneumocytes previously described by Elbert et al.
[13]. After visible bronchi were removed, the lung tissue
was sliced into pieces of about and washed at least three
times with BSS (balanced salt solution; 137 mM NaCl,
5m MK C l ,0 . 7m MN a 2HPO4, 10 mM HEPES, 5.5 mM
glucose, pH 7.4). The washing buffer was collected and
cells were obtained by centrifugation (15 min, 350 × g).
Remaining erythrocytes were lysed by incubation with
hypotonic buffer (155 mM NH4Cl, 10 mM KHCO3,
1m MN a 2EDTA) and the cell suspension was washed
with PBS (137 mM NaCl, 2.7 mM KCl, 10.1 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4) three times. Subse-
quently, cells were resuspended in MF medium (RPMI
1640, 5% FCS, 100 U/ml penicillin G, 100 μg/ml strep-
tomycin, 2 mM glutamine), seeded at a density of 0.5-
1×1 0
6 cells/well in a 12- or 6-well plate and incubated
at 37°C and 5% CO2 for 2 h. Adherent cells were washed
at least 5 times with PBS and cultivated with medium for
3-4 days. Medium was changed every two days.
Lung interstitial macrophages
After recovering alveolar macrophages, lung tissue was
chopped into pieces of 0.6 mm thickness using a McIl-
wain tissue chopper. To remove remaining alveolar
macrophages and blood cells, the tissue was washed
with BSS over a 100 μm cell strainer until the filtrate
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a combination of 150 mg trypsin type I (T-8003, Sigma-
Aldrich, Carpinteria, CA, USA) and 0.641 mg elastase
(LS022795, CellSystems, Remagen, Germany) in 30 ml
BSSB for 40 min at 37°C in a shaking water bath. After
partial digestion, the tissue was brought to DMEM/F12
medium (PAA, Pasching, Austria) containing 25% FCS
(PAA, Pasching, Austria) and 350 U/ml DNase I
(D5025, Sigma-Aldrich, St. Louis, MO, USA). Remaining
undigested lung tissue in the solution was disrupted by
repeatedly pipetting the cell suspension slowly up and
down. After filtration through gauze and a 40 μm cell
strainer, cells were incubated with a 1:1 mixture of
DMEM/F12 medium and SAGM (Cambrex, East
Rutherford, NJ, USA), containing 5% FCS and 350 U/ml
DNase I in Petri dishes in an incubator at 37°C and 5%
CO2 for 90 min in order to let macrophages attach to
the plastic surface. Afterwards, non-adherent cells were
removed by washing with PBS. As surface receptor
expression might be influenced by different isolation
procedures, cells were cultured with MF medium for 3-
4d a y st or e s t o r er e c e p t o r sa ss h o w np r e v i o u s l yf o rt i s -
s u em a c r o p h a g e si s o l a t e db ye n z y m ep e r f u s i o n[ 1 4 ] .
Medium was changed every other day.
Isolation of monocytes and cultivation of DCs
Monocytes were isolated from healthy adult blood donors
(Blood Donation Center, Saarbrücken, Germany) as
described by Schütz et al. [15]. Briefly, peripheral blood
mononuclear cells (PBMCs) were isolated from buffy
coats using Ficoll-Paque (Amersham Biosciences, Piscat-
away, NJ, USA). The cell layer containing mononuclear
cells was washed in PBS, erythrocytes lysed, and washed
again twice with PBS. Subsequently, cells were allowed to
adhere to culture flasks for 2 h at 37°C. Non-adherent
cells were removed by washing, and the adherent mono-
cytes were harvested. To generate immature DCs (iDC),
monocytes were cultured for 5 d in the presence of GM-
CSF (800 U/ml, Berlex Bioscience Inc., Richmond, CA,
USA) and IL-4 (20 U/ml, Strathmann Biotec, Hamburg,
Germany) with one-quarter of the medium being replaced
by fresh cytokine-containing medium on day 2 post-isola-
tion. Mature dendritic cells (mDC) were generated by add-
ing 100 ng/ml LPS (Sigma-Aldrich, St. Louis, MO, USA)
to iDC cultures for an additional 48 h.
Pappenheim staining
Air-dried MF preparations were stained using May-
Grünwald solution (Roth, Karlsruhe, Germany) for
5 min, followed by addition of the same volume of dis-
tilled water and incubation for another 5 min, after
which the staining solution was removed. Subsequently,
preparations were incubated with Giemsa solution (1:20;
Roth, Karlsruhe, Germany) for 15 min, washed with
distilled water and visualized using light microscopy.
RNA isolation and reverse transcription
Total RNA was extracted using either RNeasy mini or
micro kit columns (Qiagen, Hilden, Germany). DNA was
digested during the RNA isolation procedure using the
RNase-Free DNase 1 treatment kit (Qiagen, Hilden, Ger-
many). 500 ng of RNA were denatured at 65°C for 5 min,
placed on ice, and then reverse transcribed in a total
volume of 20 μl using the High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA,
USA) according to the manufacturer’s instructions.
Real-time quantitative PCR
The iCycler iQ5 (Bio-Rad, Richmond, CA, USA) was
used for real-time quantitative PCR. Primers and dual-
labelled probes were obtained from Eurofins MWG
Operon (Ebersberg, Germany). Sequences are given in
table 1 and 2. Standards, from 10 to 0.0001 attomoles of
Table 1 Primer sequences as used for real time RT-PCR
primer sense, 5′→3′ primer antisense, 5′→3′
TLR1 AGCAAAGAAATAGATTACACATCA TTACCTACATCATACACTCACAAT
TLR2 GCAAGCTGCGGAAGATAATG CGCAGCTCTCAGATTTACCC
TLR3 GAATGTTTAAATCTCACTGC AAGTGCTACTTGCAATTTAT
TLR4 ATGAAATGAGTTGCAGCAGA AGCCATCGTTGTCTCCCTAA
TLR5 GTACAGAAACAGCAGTATTTGAG TCTGTTGAGAGAGTTTATGAAGAA
TLR6 TTTACTTGGATGATGATGAATAGT AGTTCCCCAGATGAAACATT
TLR7 CCATACTTCTGGCAGTGTCT ACTAGGCAGTTGTGTTTTGC
TLR8 AAGAGCTCCATCCTCCAGTG CCGTGAATCATTTTCAGTCAA
TLR9 GGGACAACCACCACTTCTAT TGAGGTGAGTGTGGAGGT
TLR10 CAACGATAGGCGTAAATGTG GAACCTCGAGACTCTTCATTT
TNF-a CTCCACCCATGTGCTCCTCA CTCTGGCAGGGGCTCTTGAT
IL10 CAACAGAAGCTTCCATTCCA AGCAGT TAGGAAGCCCCAAG
IL6 AATAATAATGGAAAGTGGCTATGC AATGCCATTTATTGGTATAAAAAC
b-Actin TGCGTGACATTAAGGAGA AG GTCAGGCAGCTCGTAGCTCT
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Heidelberg, Germany), were run alongside the samples
to generate a standard curve. All samples and standards
were analyzed in triplicate. The PCR reaction mixture
consisted of 10 × PCR buffer (GenScript, Piscataway, NJ,
USA), either 2 or 8 mM dNTPs, 3-9 mM Mg
2+, 500 nM
sense and antisense primers, either 2.5 or 1.5 pmol of
the respective dual-labelled probe, and 2.5 U of Taq
DNA Polymerase (GenScript, Piscataway, NJ, USA) in a
total volume of 25 μl. The reaction conditions were
95°C for 8 min followed by 40 cycles of 15 s at 95°C,
15 s at a reaction dependent temperature varying from
57-60°C, and 15 s at 72°C. The starting amount of
cDNA in each sample was calculated using the iCycler
iQ5 software package (Bio-Rad, Richmond, CA, USA).
Isolation of mycobacterial DNA
Before DNA isolation, bacteria were centrifuged and
boiled for 10 min. DNA was isolated according to a pre-
viously published method [16]. Isolation was performed
under sterile conditions in order to avoid bacterial con-
tamination from the surrounding area. Additional preci-
pitation and washing steps were included to assure
purity of the DNA [17]. We checked all DNA prepara-
tions with a commercially available LAL assay (sensitiv-
ity 0.03 EU/ml; Cambrex, East Rutherford, NJ, USA) in
order to exclude LPS contaminations. Moreover,
absence of contaminants was confirmed for all DNA
preparations by DNase treatment as well as methylation
as described previously [16].
Flow cytometry
MF were detached from the plates in TEN buffer
( 4 0m MT r i s ,1m ME D T A ,1 5 0m MN a C l )b e f o r e
staining. For extracellular staining of CD83 and CD1a,
MF or DC were washed with PBS, resuspended in
FACS buffer I (PBS containing 2.5% (v/v) bovine calf
serum and 0.05% (w/v) NaN3) and then divided into ali-
quots, each containing up to 1 × 10
6 cells. Each aliquot
was incubated with a specific or isotype control antibody
for 30 min on ice. The cells were washed in FACSwash
and resuspended in 1% (w/v) cold paraformaldehyde in
PBS, pH 7.6. HLA-DR and CD14 staining were
performed similarly, except that FACS buffer II (PBS
containing 0.05% (w/v) NaN3 and 0.5% (w/v) BSA for
HLA-DR) or III (PBS with 1% (w/v) NaN3 and 0.5%
(w/v) BSA for CD14) were used instead of FACS buffer
I. Intracellular staining of CD68 was done using the
IntraStain Reagents (Dako, Carpinteria, CA, USA)
according to the manufacturer’s instructions. The
stained cells were examined on a FACSCalibur, and
results were analysed using the CellQuest software (BD
Biosciences, San Jose, CA, USA). Results are reported as
relative mean fluorescence intensity (MFI; mean fluores-
cence intensity of specifically stained cells related to
mean fluorescence intensity of isotype control).
Phagocytosis Assay
Sample preparation
To visualize the uptake of microspheres by MF,c e l l s
were incubated with 1.75 μm latex beads (Fluoresbrite
Carboxylated YG microspheres; Polysciences, Warring-
ton, PA, USA) at a 100:1 bead/cell ratio for 4 h in
medium containing 5% FCS. To block fluoresphere
uptake, cytochalasin D (10 μg/ml, Sigma-Aldrich,
St. Louis, MO, USA) was added 1 h prior to addition
of latex beads. Alternatively, MF were pretreated by
incubation for 1 h at 4°C and further incubated with
fluorespheres at the same temperature as the pretreat-
ment. After the incubation of MF with latex beads,
cells were washed 4-5 times with ice cold PBS to
remove remaining fluorospheres, and detatched from
plates using trypsin/EDTA buffer (PAA, Pasching, Aus-
tria). After washing with PBS, cells were assessed for
fluorosphere uptake by flow cytometry or confocal
laser scanning microscopy.
Flow cytometry assessment of fluorosphere uptake
Upon washing MF, cells were resuspended in ice-cold
PBS, examined on a FACSCalibur and results were ana-
lysed using the CellQuest software (BD Biosciences, San
Jose, CA, USA).
Confocal laser scanning microscopy
AM and IM were fixed for 10 min in PBS supplemented
with paraformaldehyde 3.7%, permeabilized for 10 min
with 0.25% Triton X-100, subsequently blocked for
30 minutes with BSA 1% in PBS and stained with rho-
damin-phalloidine (Sigma-Aldrich, St. Louis, MO, USA)
and TOTO-3 iodide (Invitrogen, Carlsbad, CA, USA).
Images were captured using a LSM 510 Meta (Carl
Zeiss, Oberkochen, Germany).
Table 2 Probe sequences as used for real time RT-PCR
probe, 5’ FAM →3’ BHQ1
TLR1 ATTCCTCCTGTTGATATTGCTGCTTTTG
TLR2 ATGGACGAGGCTCAGCGGGAAG
TLR3 TTCAGAAAGAACGGATAGGTGCCTT
TLR4 AAGTGATGTTTGATGGACCTCTGAATCT
TLR5 AGGATCTCCAGGATGTTGGCTG
TLR6 GTCGTAAGTAACTGTCZGGAGGTGC
TLR7 ATAGTCAGGTGTTCAAGGAAACGGTCTA
TLR8 TGACAACCCGAAGGCAGAAGGCT
TLR9 ACTTCTGCCAGGGACCCACGG
TLR10 ATTAGCCACCAGAGAAATGTATGAACTG
TNF-a CACCATCAGCCGCATCGCCGTCTC
IL10 AGCCTGACCACGCTTTCTAGCTGTTGAG
IL6 TCCTTTGTTTCAGAGCCAGATCATTTCT
b-Actin CACGGCTGCTTCCAGCTCCTC
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A Ma n dI Mw e r es e e d e da tad e n s i t yo f1×1 0
5 cells
per well in 96 well plates. On day 4 post seeding, cells
were incubated in a total volume of 100 μlm e d i u mi n
the presence or absence of LPS (100 ng/ml) for 6 h. The
supernatants were collected and stored at -80°C until
use in the multiplex cytokine assay. For cytokine mea-
surement, a Milliplex MAP Human Cytokine Kit (Milli-
pore, Billerica, MA, USA) was used, containing the
following cytokines: IL1b, IL1ra, IL6, IL10, IL12p40, IL-
12p70 and IFNg. The immunoassay procedure was per-
formed using a serial dilution of the 10,000 pg/ml
human cytokine standard according to the manufac-
turer’s instructions and the plate was read at the Lumi-
nex 200 System (Luminex, Austin, TX, USA). Total
cellular protein concentrations were determined by
Pierce BCA protein assay (Fisher Scientific, Nidderau,
Germany) using a Sunrise absorbance reader (Tecan,
Grödig, Austria) according to the manufacturer’s
instructions.
Electron Microscopy
AM and IM were fixed with 0.12 M PBS supplemented
with 1% (w/V) paraformaldehyde and 1% (w/V) glutar-
dialdehyde. Wet samples were washed with distilled
water before mounting on a Peltier stage cooling the
sample down to 276 K. After purging the vacuum cham-
ber in wet conditions samples were carefully dried to
P = 500 Pa and measured under a tilting angle of 45°
and an accelerating voltage of E = 5 kV with a Quanta
400 ESEM FEG (FEI, Hillsboro, OR, USA).
Statistics
Data analysis and statistics were performed using Origin
software (OriginPro 7.5G; OriginLabs, Northampton,
MA, USA). All data are displayed as mean values ±
SEM. Statistical differences were estimated by indepen-
dent two-sample t-test. Differences were considered sta-
tistically significant when P values were less than 0.05.
Results
Cell number and appearence
The AM and IM fractions obtained from 30 - 50 g of
lung tissue each contained 2-20 × 10
6 cells, with the
number of IM being equal to or exceeding the number
of AM. The overall viability of cells obtained by washing
or enzyme digestion of lung tissue was > 90% as deter-
mined by trypan blue staining.
Both AM and IM preparations almost exclusively con-
tained highly auto-fluorescent cells compared to low
fluorescent cells like DC, as observed by flow cytometry
and fluorescence microscopy (data not shown).
AM populations consisted mostly of large, round cells
heterogeneous in size whereas IM appeared to be
smaller but more heterogeneous in shape compared to
AM as observed by light and electron microscopy
(figure 1A, B). FACS analysis assessing FSC confirmed
the smaller size of IM (figure 1C).
Phenotypic differences could be seen directly after iso-
lation and persisted for at least 5 days. As tissue macro-
phages isolated by enzyme perfusion have been shown
previously to require several days to recover surface
receptor functionality [14], cells were cultured 3-4 days
before use for further experiments.
Since the presence of fibroblasts can alter phagocyte
functions [18,19] we determined a potential contamina-
tion with this cell type. However, neither AM nor IM
exhibited a significant contamination with fibroblasts as
shown by immunostaining of CD90. The surface marker
is highly expressed in fibroblasts [20,21], as we con-
firmed for the human fibroblast cell lines MRC-5 and
HSF-1 (data not shown). In contrast, CD90 is expressed
only to a very low extent in macrophages, as was shown
in the literature [20,21] and confirmed by ourselves in
human differentiated THP-1 macrophages (data not
shown). CD90 staining of AM and IM preparations
revealed that mean percentages of CD90 positive cells
were very low (0.9 ± 0.5% in AM vs. 1.3 ± 0.5% in IM)
and did not significantly differ between the two cell
types (figure 1D).
Expression of intracellular and surface markers
In order to define potential phenotypic differences
between AM and IM, we analyzed their expression of
the cell-surface molecules CD14 and human leukocyte-
associated antigen-DR (HLA-DR). Moreover, the expres-
sion of surface markers CD83 and CD1a as well as
intracellular CD68 in both populations was compared to
in vitro d i f f e r e n t i a t e di D Ca n dm D C .A m o n gt h ec e l l -
surface molecules studied, only the expression of HLA-
DR displayed significant differences between IM and
AM, whereas CD14 expression was low or not detect-
able in both cell types (figure 2A, B). With respect to
donor dependent differences in absolute MFI values,
H L A - D R - e x p r e s s i o ni nI Mw a sa l m o s t3 - f o l dh i g h e r
than in AM. CD68, often used as a specific marker for
MF [5,22,23], was highly expressed in both AM and
I M ,b u tc o u l da l s ob ef o u n di ni D Ca sw e l la sm D C .
The dendritic cell markers CD1a and CD83 were not
detectable in both AM and IM (figure 3). These data
suggest that IM share many phenotypic characteristics
with AM, whereas no similarities to dendritic cells were
observed.
Phagocytosis
The internalization of fluorescent latex beads by MF
was quantified by flow cytometry. After incubation
with fluorescent particles for 4 h, about two thirds of
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Particle uptake was significantly lowered by the pre-
treatment of the cells with cytochalasin D or incuba-
tion with fluorospheres at 4°C, but it was not
abrogated completely (figure 4A and 4B). This might
be due to particle attachment to the cell surface,
which can not be distinguished from particle internali-
zation by flow cytometry. Therefore, fluorosphere
uptake was visualized by confocal laser scanning
microscopy. Upon incubation with the fluorescent
particles for 4 h, most MF had internalized several
fluorospheres. As most of the particles were found to
be internalized and not attached to the surface,
quenching was supposed not to be necessary for flow
cytometry analysis. Pretreatment with cytochalasin D
or incubation at 4°C for 1 h prior to particle addition
blocked particle uptake completely (figure 4C). Pre-
treatment of MF with DMSO, the solvent used for
cytochalasin D, did not affect particle uptake (data not
shown).
Figure 1 Morphology and CD90 staining.M F visualization by Pappenheim staining (A) and electron microscopy (B). Images are
representative for cell preparations from at least two different donors. C: Comparison of MF sizes by forward scatter as measured by flow
cytometry. Light grey line: IM; filled/dark grey: AM. D: CD90 staining of AM and IM. Filled/dark grey: isotype control; light grey line: antibody
staining. MFI values are given within graphs. Data show one representative out of three independent experiments with cells obtained from
different donors.
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To investigate the expression of TLR1-10, we performed
real time RT-PCR with samples from untreated AM and
IM. TLR mRNA expression levels were not significantly
different in AM and IM (figure 5). Among the TLRs
recognizing bacterial patterns, TLR1, 2 and 4 were
expressed strongest, whereas TLR8 as a sensor of viral
infections showed highest expression of the RNA-
responsive receptors.
Cell reaction upon TLR4/9 stimulation
As most comparative data for AM and IM focuses on
TLR4 activation, we treated respective cell populations
with LPS and then determined induction of cytokine
mRNA. Though we observed an increase in TNF-a,
IL10 and IL6 mRNA in both cell types, the extent of
TNF-a induction observed in IM was weak compared
t ot h ei n c r e a s eo fc y t o k i n ei n d u c t i o ni nA M .I M
expressed both more IL6 and IL10 mRNA upon TLR4
activation than AM (figure 6). Interestingly, AM and IM
differed also largely in basal IL10 and IL6 mRNA levels
with IL10 expression in IM exceeding IL10 expression
in AM 9.7-fold (± 2.4) and IL6 expression in IM being
16.9-fold (± 3.8) higher compared to AM (figure 6).
These high basal expression levels of IL6 and IL10 in
IM are also the reason why x-fold cytokine mRNA
Figure 2 CD14 and HLA-DR expression. AM and IM were stained and analyzed by flow cytometry. A: Data show one representative out of
four independent experiments. Filled/dark grey: isotype control; light grey line: antibody staining. B: Comparison of AM and IM concerning CD14
and HLA-DR expression. Data are expressed as MFI related to AM values. Data show means ± SEM of four independent experiments with cells
derived from four different donors. *P < 0.05 compared to AM values.
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untreated controls were higher in AM for all cytokine
mRNAs investigated (figure 6D).
AM have only recently been shown to be highly acti-
vated by BCG DNA as TLR9 ligand despite low TLR9
expression levels [16]. Due to this interesting fact, we
decided to also test responsiveness of IM towards TLR9
ligands. Cells were treated with different stimuli includ-
ing a CpG-containing oligonucleotide (phosphorothio-
ate-modified immunostimulatory sequence ISS 1018, 5′-
TGACTGTGAACGTTCGAGATGA-3′)a n dg e n o m i c
DNA isolated from the attenuated M. bovis BCG strain.
As reported previously for in vitro differentiated MF
[16], TNF-a induction by ISS was weak or absent in both
cell types. Treatment with BCG DNA resulted in a mark-
edly stronger TNF-a induction in AM, but an only mod-
erate response in IM (figure 7A). Interestingly, AM
completely lacked IL10 induction upon stimulation with
BCG DNA, whereas IM showed a distinct IL10 induction
upon TLR9 activation (figure 7C). IL6 was induced in
both cell types (figure 7E). The extent of IL10 as well as
IL6 induction by ISS was minimal in both AM and IM.
Next, we examined cell reaction upon treatment with
DNA from virulent (H37Rv) or attenuated (H37Ra)
mycobacteria. Both AM and IM treated with DNA from
virulent bacteria (H37Rv) showed a minimal induction
of TNF-a compared to cells treated with DNA from
non-virulent Mycobacteria(H37Ra, figure 7B; BCG, fig-
ure 7A). The lack of IL10 and IL6 induction by H37Rv
DNA confirmed its low activatory potential (figure 7D,
F). Observations for H37Ra DNA complied with the
findings for BCG-DNA for both AM and IM, i.e. high
TNF-a induction and absence of IL10 induction in AM
contrasting a distinct IL10 response in IM.
Taken together, these data obtained on mRNA level
suggested that the activation profiles of AM and IM
upon TLR4 and TLR9 stimulation are markedly differ-
ent, indicating that both cell types clearly differ in func-
tional properties. We therefore extended cytokine
mRNA profiling of IL10 and IL6 to protein quantifica-
tion using a fluorescent bead-based immunoassay and
additionally determined the cytokine levels of IL1 recep-
tor antagonist (IL1ra), IL1b, IL12p40, IL12p70, and
interferon (IFN)-g at baseline and after LPS activation in
Figure 3 Expression of CD68, CD83 and CD1a. AM and IM as well as in vitro differentiated iDC and mDC were stained and analyzed by flow
cytometry. Filled/dark grey: isotype control; light grey line: antibody staining. MFI values are given within graphs. Data show one representative
out of three independent experiments with cells originating from different donors.
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Page 8 of 15AM and IM. These data revealed that AM and IM con-
stitutively produced IL10, IL6, and IL1ra. Most remark-
ably, the baseline production of these anti-inflammatory
and regulatory cytokines was markedly higher in IM
than in AM. In detail, IL10 secretion was 1.9-fold
(± 0.2), IL6 secretion 3.3-fold (± 0.4), and IL1ra
production 2.5-fold (± 0.4) higher in IM compared to
AM (figure 8A-C). Upon LPS treatment, IM still pro-
duced significantly more IL10 as well as IL1ra than AM.
In contrast, production of the proinflammatory cyto-
kines IL1b and IL12p40 following LPS activation was
significantly higher in AM compared to IM. IFNg and
Figure 4 Phagocytic Activity. AM and IM were cultured with fluorescent FITC-labeled microspheres for 4 h at 37°C. As a control experiment,
cells were pretreated with cytochalasin D (10 μg/ml, CytD) for 1 h. Alternatively, cells were preincubated at 4°C for 1 h and incubated with
microspheres for 4 h at 4°C afterwards. Experiments were performed with cells derived from at least three different donors. A, C: representative
results are shown. A: Fluoresphere-associated fluorescence (marked with black bars) was detected in AM and IM using flow cytometry. B:
Average of percentage of MF positive for fluorosphere-associated fluorescence. Data represent mean ± SEM. *P < 0.05 as compared to cells left
untreated at 37°C. C: Particle uptake in AM and IM was visualized by CLSM. F-actin was stained with rhodamin-phalloidine (red), nuclei with
TOTO-3 iodide (blue). Latex beads are shown in green. Co: untreated cells.
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Page 9 of 15IL12p70 were actually only secreted by AM, but not by
IM, upon LPS challenge (figure 8D).
The production of higher amounts of inflammatory
cytokines in AM compared to IM did not induce cell
death as determined by MTT assay (data not shown).
Discussion
Isolation procedure
Human IM are less accessible than AM, which is why
IM have in the past mostly been characterized using
animal models [4,24]. Our approach for MF isolation
from human lung interstitial was based on a previously
described method for isolation of epithelial cells [13]
and allows parallel isolation of AM, IM and epithelial
c e l l s .T h ed i g e s t i o np r o c e d u r et h a tw eu s e ds l i g h t l yd i f -
fered from those previously described for isolation of
human IM [6,7].
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Figure 5 Toll-like receptor expression. RNA was isolated from AM
and IM and real-time RT PCR analysis for TLR1-10 was performed.
Data were normalized to b-Actin values. Data show means ± SEM
of independent experiments performed with cells from 3 to 4
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Page 10 of 15We are aware that donor specifics such as medica-
tion or smoking behaviour might alter MF func-
tions. In fact, smoking has been shown previously to
increase basal levels of TNF-a,I L 1o rI L 8i nh u m a n
AM [25] and to cause changes in morphology and
surface molecule expression in rat AM [4]. Never-
theless, our results reveal many similarities of AM
from lung tissue compared to AM from bronchoal-
veolar lavage described in the literature, as detailed
below.
Morphology
H u m a na sw e l la sr a tA Mw e r ep r e v i o u s l yd e s c r i b e da s
large, mature cells, which closely resemble other tissue
macrophages [6,24]. In contrast, IM of human, rat or
hamster origin were shown to be smaller than AM,
m o r eu n i f o r mi ns i z ea n dt og e n e r a l l yr e s e m b l em o r e
closely peripheral blood monocytes [5,24,26,27]. Our
findings were similar to those described in the literature,
which indicates that we were able to successfully sepa-
rate MF populations.
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Figure 7 Activation of AM and IM by TLR9 ligands. AM or LTM were left untreated (Co) or incubated with TLR9 ligands, followed by RNA
isolation and real-time PCR analysis for TNF-a (A, B), IL10 (C, D) or IL6 (E, F). A, C, E: Cells were treated either with immunostimulatory sequences
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Page 11 of 15CD14 and HLA-DR expression
Studies using primary rat AM and IM suggest that AM
and IM do not differ in CD14 expression [4]. We were
able to show that CD14 is marginally expressed in
h u m a nA Ma sw e l la sI M .L o wC D 1 4e x p r e s s i o nw a s
reported previously for human AM obtained from
bronchoalveolar lavage [28,29]. CD14 expression by
human IM is not described in the literature, but our
results resemble findings reported for other tissue
macrophage populations [28].
Several studies using rat, mouse as well as human MF
reported a higher MHC-II expression in IM compared
to AM [4,5,7,30]. Our own results resemble those find-
ings, indicating that IM are more involved in acquired
immune response than AM.
Comparison to dendritic cells
Lung DC are a small subset of pulmonary mononuclear
cells which exhibit low autofluorescence and are known
to be loosely adherent [8,31-34]. Moreover, this cell type
possesses an immature phenotype along with a rather
weak CD83 expression [8]. Subsets of lung DC are
known to express CD1a [31]. Both our MF preparations
displayed high autofluorescence, were highly adherent
and shared no phenotypic characteristics with DC
regarding CD83 or CD1a expression. Therefore, the pre-
sence of DC in our cell preparations can be excluded
for the most part.
Phagocytic Activity
Both MF types displayed phagocytic activity, which
underlines the macrophage phenotype of IM. Phagocytic
activity was comparable in AM and IM. This finding
resembles observations for Fcg-dependent phagocytosis
in the animal model [4]. Differences in phagocytic activ-
ity have been shown previously for human AM and IM
phagocytosing Saccharomyces cerevisiae[6]. As this pro-
cess is Fcg-independent, these findings can not be com-
pared to our results.
Toll-like receptor expression
In the present study, expression of TLR1-10 mRNA
levels were examined in both AM and IM for the first
time. TLR1-10 mRNA expression by AM obtained from
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Figure 8 LPS-induced cytokine secretion. AM or IM were left untreated (Co) or treated with LPS (100 ng/ml) for 6 h. Supernatants were
removed and used for measurement of cytokine protein production. Data are normalized to total cellular protein values. Data show means ±
SEM of 2-4 independent experiments performed in triplicate with cells derived from different donors. *P < 0.05.
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Page 12 of 15bronchoalveolar lavage was previously described by
Maris et al. [35]. According to this study, TLR1, TLR4,
TLR7, TLR8 are strongly and TLR2, TLR6 weakly
expressed, whereas TLR3, TLR5, TLR9 and TLR10 were
not detectable. Our results for TLR1, TLR4, TLR6,
TLR8 and TLR10 expression by AM resemble those
observations. In contrast to Maris et al., we observed a
strong expression of TLR2 mRNA which is in line with
results by Suzuki et al. [36] as well as ourselves [16].
Contrary to Maris et al. we were able to detect TLR3,
TLR5 and TLR9 mRNA, suggesting a higher sensitivity
of our assay. In fact, our real time PCR analysis is linear
over 8 orders of magnitude, down to a concentration of
10
-6 attomole/μl.
It was long believed that both human monocytes as well
as human macrophages do not express TLR9 [37]. This
view was supported by examinations like that by Miettinen
et al. [38], failing to detect TLR9 mRNA by Northern Blot
in human macrophages. By now, the presence of TLR9 in
MF was confirmed by Fenhalls et al. [39], Juarez et al.
[40], and ourselves [16] by immunhistochemichal detec-
tion, Western blot analysis, flow cytometry, real time
RT-PCR, and evidence of TLR9 functionality.
No significant differences between AM and IM con-
cerning the TLR mRNA expression profile were found.
Still, we can not exclude that TLR protein expression or
localization differ in the different macrophage popula-
tions, which might both cause a differential cell reaction
upon ligand binding.
Cell reaction upon TLR activation
Previous studies using rat MF revealed that upon TLR4
stimulation AM express higher amounts of the proin-
flammatory cytokine TNF-a compared to IM [4,9]. Our
d a t as u g g e s tt h a tt h i si sa l s ot r u ef o rh u m a nA Ma n d
IM. Moreover, we were able to detect significant differ-
ences between AM and IM concerning IL10 as well as
IL6 expression.
Although IL10 is one of the most important anti-
inflammatory mediators in human immune response
[41,42], its expression by human AM and IM has not
been investigated before. AM display low basal IL10
levels, which might allow efficient defence against
inhaled particles and pathogens, whereas the fast induc-
tion of IL10 upon LPS treatment suggests an autoregu-
latory mechanism. As forI M ,b a s a lI L 1 0m R N Aa n d
protein levels were found to be significantly higher than
in AM and to increase after LPS treatment. A recently
published study comparing murine AM and IM showed
that IL10 levels were markedly higher in IM [5]. Our
data demonstrate that this is also true for human IM. In
the animal model, IM were shown to inhibit lung DC
maturation and migration in an IL10-dependent man-
ner, thereby preventing Th2 sensitization to harmless
inhaled antigens [5]. Our findings suggest that this
might also be exhibited by human IM, indicating that
IM play a crucial role in immune homeostasis.
IL6 has proinflammatory as well as anti-inflammatory
properties. Studies using knockout mice demonstrated
that in innate immunity IL6 acts predominantly as an
antiinflammatory cytokine, mainly by attenuating the
synthesis of proinflammatory cytokines [43,44]. More-
over, IL6 is involved in the specific immune response by
upregulating B-cell differentiation, T-cell proliferation,
and antibody secretion [44]. The high constitutive
expression of IL6 that we found in IM both on mRNA
and protein level indicates that IM display a pronounced
immunoregulatory capacity and suggests that they are
more involved in specific immune responses.
IL1ra is a major antiinflammatory cytokine that func-
tions as a specific inhibitor of the two other functional
members of the IL-1 family, IL-1a and IL-1b [41,45].
Our data demonstrate that IM secrete higher amounts
of IL1ra when compared to AM, both at baseline and
upon TLR4 activation. In contrast, LPS induced secre-
tion of proinflammatory cytokines was low in IM when
compared to AM (IL1b, IL12p40) or even completely
absent (IL12p70 and IFNg). These findings clearly
underline the anti-inflammatory phenotype of IM pre-
viously described in the literature based on data
obtained from murine or rat MF [4,5,9,24].
Despite the weak expression of TLR9 in AM and IM,
cells reacted strongly upon stimulation with mycobac-
terial DNA. Methylation or digestion of mycobacterial
DNA as well as chloroquine pretreatment lead to an
abrogation of the macrophage response [16], which indi-
cates that gene expression upon treatment with isolated
DNA is not due to contaminants in DNA preparations,
but due to TLR9 activation. It has been shown pre-
viously for human in vitro differentiated MF as well as
am o u s eM F cell line that TLR9 activation is higher
upon treatment with bacterial DNA than after oligonu-
cleotide treatment, which might be due to oligonucleo-
tide structure [16,46,47]. Moreover, it has been reported
for human in vitro differentiated macrophages as well as
for AM from BAL that DNA from virulent strains has a
lower potential to activate TLR9 in MF than DNA from
attenuated strains [16]. Several studies indicate that the
virulent H37Rv strain is able to methylate cytosines
whereas the H37Ra strain is not [48,49], which might
explain why H37Rv DNA fails to activate TLR9.
We were able to show that IM are less responsive to
bacterial DNA than AM concerning TNF-a induction,
which resembles our findings for TLR4 activation. Simi-
lar to the results of the TLR4 activation experiments,
I L 6a sw e l la sI L 1 0e x p r e s s i o nw e r em u c hh i g h e ri nI M
compared to AM, which clearly underlines the immuno-
regulatory function of IM.
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Page 13 of 15Moreover, IL10 was only induced in IM, but not in
AM, upon mycobacterial DNA treatment. Absence of
IL10 induction after TLR9 activation by mycobacterial
DNA has been reported before [40] and might be part
of a mechanism of AM to overcome the immunosup-
pressive environment of the alveoli. Lung epithelial cells
have been shown to constitutively express IL10, which is
accompanied by an impaired responsiveness of AM
towards IL10 [50]. In the same study, it was also
observed that activation of human AM through TLR2,
TLR4 or TLR9 leads to inhibition of IL10 receptor func-
tion associated with a reduced ability to activate STAT3.
As IL10 is known to induce its own transcription via
several positive feedback loops involving STAT3 [51,52],
a low capacity of AM to activate STAT3 might contri-
bute to the lack of IL10 induction in AM upon TLR9
activation as well as to the low basal levels of IL10 in
comparison to IM.
Conclusion
Taken together, the present results confirm and extend
limited data obtained with murine and human AM and
IM characterizing phenotypic differences. We were able
to demonstrate functional and morphological differences
as well as similarities between AM and IM from human
lung tissue, leading to the conclusion that the heteroge-
nity of lung macrophages should be taken into consid-
eration in future studies on their role in TLR-mediated
inflammatory response.
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